Tailored Yoga Therapy for Attention-deficit Hyperactivity Disorder

计划入组 20 人 · 首次发布于 2026 年 4 月 21 日

Pharmacogenetic Studies on Attention Deficit Hyperactivity Disorder

计划入组 240 人 · 首次发布于 2009 年 6 月 10 日

Developmental Origins of Attention Deficit Hyperactivity Disorder

计划入组 24 人 · 首次发布于 2013 年 11 月 13 日

sodium hydrogen exchanger 9 inhibitors (attention deficit hyperactivity disorder)

Methylphenidate(Adhansia, Aptensio, Biphentin, Concerta, Cotempla, Daytrana, Foquest, Jornay, Metadate, Methylin, Quillichew, Quillivant, Relexxii, Ritalin, Tuzulby)

C₁₄H₁₉NO₂

Dextroamphetamine(Adderall, Dexedrine, Mydayis, Procentra, Xelstrym, Zenzedi)

C₉H₁₃N

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

United States

Vanda Pharmaceuticals

United States

Alzamend Neuro

United States

Lupin Receives FDA Approval for Generic Adderall XR Capsules

Lupin Gains USFDA Approval for Generic Adderall XR for ADHD Treatment

Elite Pharmaceuticals Gains FDA Approval for Generic Vyvanse